We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KL
1051
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$398K 0.01%
10,326
-393
-4% -$15.8K
AKAM icon
1052
Akamai
AKAM
$15.9B
$397K 0.01%
+3,409
New +$380K
ARR
1053
Armour Residential REIT
ARR
$2.36B
$397K 0.01%
+6,960
New +$418K
COHR
1054
PUT
DELISTED
Coherent Inc
COHR
$397K 0.01%
1,500
+500
+50% +$131K
CAH icon
1055
Cardinal Health
CAH
$55.4B
$396K 0.01%
6,881
-2,041
-23% -$119K
ZD icon
1056
Ziff Davis
ZD
$1.98B
$394K 0.01%
+3,291
New +$362K
MCS icon
1057
Marcus Corp
MCS
$945M
$393K 0.01%
18,508
+5,883
+47% +$122K
DNLI icon
1058
Denali Therapeutics
DNLI
$3.97B
$391K 0.01%
+4,983
New +$308K
FE icon
1059
FirstEnergy
FE
$27.5B
$390K 0.01%
10,483
-32,383
-76% -$1.2M
MDU icon
1060
MDU Resources
MDU
$4.32B
$390K 0.01%
+32,771
New +$411K
MAG
1061
DELISTED
MAG Silver
MAG
$389K 0.01%
18,583
+3,300
+22% +$65.4K
UCTT
1062
Ultra Clean Holdings
UCTT
$3.95B
$389K 0.01%
+7,237
New +$387K
BNR
1063
Burning Rock Biotech
BNR
$92.9M
$388K 0.01%
1,316
+66
+5% +$19.5K
FDS icon
1064
Factset
FDS
$10.2B
$388K 0.01%
1,155
+236
+26% +$77.3K
TTWO icon
1065
Take-Two Interactive
TTWO
$46.1B
$387K 0.01%
+2,185
New +$388K
XOP icon
1066
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$387K 0.01%
4,000
-72,800
-95% -$6.36M
MANH icon
1067
Manhattan Associates
MANH
$11.4B
$386K 0.01%
2,668
+526
+25% +$70.1K
SF
1068
Stifel
SF
$12.6B
$386K 0.01%
+8,930
New +$400K
HHLA
1069
DELISTED
HH&L Acquisition Co.
HHLA
$383K 0.01%
+39,438
New +$385K
INCY icon
1070
Incyte
INCY
$24.4B
$382K 0.01%
4,545
-3,637
-44% -$303K
T icon
1071
AT&T
T
$163B
$382K 0.01%
17,584
-3,792
-18% -$86.3K
IVAN.U
1072
DELISTED
Ivanhoe Capital Acquisition Corp. Unit, each consisting of one Class A ordinary share and one-third
IVAN.U
$379K 0.01%
35,265
AMT icon
1073
PUT
American Tower
AMT
$80.4B
$378K 0.01%
1,400
CRWD icon
1074
CALL
CrowdStrike
CRWD
$218B
$377K 0.01%
+6,000
New +$323K
CSTL icon
1075
Castle Biosciences
CSTL
$979M
$377K 0.01%
+5,143
New +$340K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.